Constitutive activation of Stat3 signaling pathway in human colorectal carcinoma - PubMed (original) (raw)
Constitutive activation of Stat3 signaling pathway in human colorectal carcinoma
Xiang-Tao Ma et al. World J Gastroenterol. 2004.
Abstract
Aim: Signal transducers and activators of transcription (STATs) are a family of transcription factors activated in response to cytokines and growth factors. Constitutive activation of Stat3 has been observed in a growing number of tumor-derived cell lines, as well as tumor specimens from human cancers. The purpose of this study was to investigate the expression of p-Stat3, activated form of Stat3, and its downstream mediators including cyclin D1 and Bcl-x(L) in colorectal carcinoma (CRC), and to explore the possible mechanism of Stat3 signaling pathway in the tumorigenesis of colorectal carcinoma.
Methods: Tissue samples from 45 patients of primary colorectal carcinoma were selected for studying Stat3 signaling pathway protein expression. Western blot analysis was used to measure the expression of p-Stat3, cyclin D1, and Bcl-x(L) proteins in colorectal carcinomas. Furthermore, the expression patterns of these proteins were analyzed for their distribution at the cellular level by immunohistochemical staining of the tissues.
Results: Protein levels of p-Stat3, cyclin D1, and Bcl-x(L) were increased in colorectal carcinomas compared with adjacent normal mucosae (P<0.05). Elevated levels of p-Stat3 were correlated with the nodal metastasis and the stage (P<0.05). Overexpression of cyclin D1 was associated with the nodal metastasis (P<0.05). There was also a significant correlation between the expressions of p-Stat3 and cyclin D1 (r=0.382, P<0.05).
Conclusion: Constitutive activation of Stat3 may play an important role in the tumorigenesis of colorectal carcinoma, and the detailed mechanism of Stat3 signaling pathway in CRC deserves further investigation.
Figures
Figure 1
Expressions of Stat3, p-Stat3, cyclin D1, and Bcl-xL in colorectal carcinoma. Lysates were made as described under Materials and Methods. GAPDH represents the internal pro-tein control. Elevated levels of Stat3, p-Stat3 (Tyr-705), cyclin D1, and Bcl-xL in tumor (T) tissues were compared to adjacent normal mucosae (N).
Figure 2
Expressions of Stat3, p-Stat3, cyclin D1, and Bcl-xL in colorectal carcinoma. A: Cytoplasmic staining of Stat3 in CRC (original magnification × 200) ; B: Nuclear staining of p-Stat3 in CRC (original magnification × 200) ; C: Nuclear staining of cyclin D1 in CRC (original magnification × 200) ; D: Cytoplasmic staining of Bcl-xL (original magnification × 200).
Similar articles
- [Relationship of Stat3 and its target gene products with malignancy in human colorectal carcinoma].
Ma XT, Wang S, Ye YJ, Du RY, Cui ZR. Ma XT, et al. Ai Zheng. 2003 Nov;22(11):1135-9. Ai Zheng. 2003. PMID: 14613639 Chinese. - Expression of p-STAT3 in human colorectal adenocarcinoma and adenoma; correlation with clinicopathological factors.
Kusaba T, Nakayama T, Yamazumi K, Yakata Y, Yoshizaki A, Nagayasu T, Sekine I. Kusaba T, et al. J Clin Pathol. 2005 Aug;58(8):833-8. doi: 10.1136/jcp.2004.023416. J Clin Pathol. 2005. PMID: 16049285 Free PMC article. - STAT proteins: novel molecular targets for cancer drug discovery.
Turkson J, Jove R. Turkson J, et al. Oncogene. 2000 Dec 27;19(56):6613-26. doi: 10.1038/sj.onc.1204086. Oncogene. 2000. PMID: 11426647 Review. - STAT proteins: from normal control of cellular events to tumorigenesis.
Calò V, Migliavacca M, Bazan V, Macaluso M, Buscemi M, Gebbia N, Russo A. Calò V, et al. J Cell Physiol. 2003 Nov;197(2):157-68. doi: 10.1002/jcp.10364. J Cell Physiol. 2003. PMID: 14502555 Review.
Cited by
- The Role of Tumor Stem Cells in Colorectal Cancer Drug Resistance.
Zhong C, Wang G, Guo M, Zhu N, Chen X, Yan Y, Li N, Yu W. Zhong C, et al. Cancer Control. 2024 Jan-Dec;31:10732748241274196. doi: 10.1177/10732748241274196. Cancer Control. 2024. PMID: 39215442 Free PMC article. Review. - The Insulin-like Growth Factor System and Colorectal Cancer.
Gligorijević N, Dobrijević Z, Šunderić M, Robajac D, Četić D, Penezić A, Miljuš G, Nedić O. Gligorijević N, et al. Life (Basel). 2022 Aug 20;12(8):1274. doi: 10.3390/life12081274. Life (Basel). 2022. PMID: 36013453 Free PMC article. Review. - Drug Resistance in Colorectal Cancer: From Mechanism to Clinic.
Wang Q, Shen X, Chen G, Du J. Wang Q, et al. Cancers (Basel). 2022 Jun 14;14(12):2928. doi: 10.3390/cancers14122928. Cancers (Basel). 2022. PMID: 35740594 Free PMC article. Review. - Inflammatory bowel disease-related colorectal cancer: Past, present and future perspectives.
Majumder S, Shivaji UN, Kasturi R, Sigamani A, Ghosh S, Iacucci M. Majumder S, et al. World J Gastrointest Oncol. 2022 Mar 15;14(3):547-567. doi: 10.4251/wjgo.v14.i3.547. World J Gastrointest Oncol. 2022. PMID: 35321275 Free PMC article. Review. - Mechanism of Pterostilbene-Induced Cell Death in HT-29 Colon Cancer Cells.
Wawszczyk J, Jesse K, Smolik S, Kapral M. Wawszczyk J, et al. Molecules. 2022 Jan 7;27(2):369. doi: 10.3390/molecules27020369. Molecules. 2022. PMID: 35056682 Free PMC article.
References
- Jemal A, Thomas A, Murray T, Thun M. Cancer statistics, 2002. CA Cancer J Clin. 2002;52:23–47. - PubMed
- Jin F, Devesa SS, Chow WH, Zheng W, Ji BT, Fraumeni JF, Gao YT. Cancer incidence trends in urban shanghai, 1972-1994: an update. Int J Cancer. 1999;83:435–440. - PubMed
- Darnell JE. STATs and gene regulation. Science. 1997;277:1630–1635. - PubMed
- Levy DE, Darnell JE. Stats: transcriptional control and biological impact. Nat Rev Mol Cell Biol. 2002;3:651–662. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous